Travere Therapeutics Sees Surge in Sales Following FILSPARI Approval for FSGS
- Published
On April 13, 2026, the FDA granted Travere Therapeutics full approval for FILSPARI, a treatment for focal segmental glomerulosclerosis (FSGS). This marked the drug's second full approval, following a previous clearance for IgA nephropathy in 2023. The approval is significant for patients aged 8 and older with specific subtypes of FSGS, as it offers a new FDA-approved option for a previously underserved condition.
The approval is crucial as FSGS can lead to kidney failure, and patients have historically relied on off-label therapies. Travere's Chief Executive Eric Dube emphasized the milestone for FSGS patients, while industry leaders noted the life-changing potential of the drug. Following the approval, Travere reported substantial sales growth, with FILSPARI's U.S. net product sales reaching $105.2 million in Q1 2026, an 88% increase from the previous year, and $141.1 million in Q2 2026, a 96% year-over-year rise.
Looking ahead, Travere's first-half 2026 sales totaled $246.2 million, indicating strong market demand for FILSPARI. The company also reported its first quarter of non-GAAP profitability. No further timeline was disclosed at the time of publication.
Original report
Travere Therapeutics Turns a Rare Disease Approval into Two Quarters of Accelerating Sales
RoboticsAndAutomationNews.com · David EdwardsThis briefing is an independently written summary based on publicly available reporting and is provided for industry information and news discovery. The original report and source publication are credited and linked where applicable. RobotToday does not claim ownership of third-party source material.
Rights concerns? Contact [email protected] with the relevant URL and details. We will review the matter and take appropriate action where warranted.
More related news
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
Related Suppliers
DEKA Research & Development
United States
US private R&D firm founded 1982 by Dean Kamen in Manchester, NH; developer of the FDA-approved LUKE robotic prosthetic arm and co-founder of FIRST Robotics.
Yuwell Medical Equipment & Supply Co., Ltd. 江苏鱼跃医疗设备股份有限公司
China
Chinese medical device maker founded 1998; produces oxygen concentrators, CPAP, and glucose monitors sold in 131 countries. ISO 13485, CE, FDA certified.
JL MAG Rare-Earth Co., Ltd. 江西金力永磁科技股份有限公司
China
Ganzhou, Jiangxi magnet maker founded in 2008, dual-listed in Shenzhen and Hong Kong; runs five plants with 40,000 tons per year of NdFeB capacity.
USA Rare Earth
United States
US rare earth mine-to-magnet company manufacturing sintered NdFeB permanent magnets in Oklahoma for robotics, defense, aerospace, and EV applications.
Zollern GmbH & Co. KG
Germany
German 300-year-old family-owned industrial group manufacturing gearboxes, drives, castings, and automation systems for robotics and heavy industry.
Beijing Co&Co Intelligent Technology Co., Ltd. 北京可安可智能科技有限公司
China
Beijing Co&Co builds outdoor, quadruped, and multimedia inspection robots with triple-lidar sensing for parks, energy sites, and transit facilities.
ViscoTec America Inc.
United States
ViscoTec America (Kennesaw, GA) is the US subsidiary of German dosing specialist ViscoTec (est. 1997), making precision dispensing systems for e-mobility.
Varda Space Industries
United States
Varda Space Industries is a US in-space manufacturing company that produces pharmaceuticals in microgravity orbit and returns them to Earth via reentry capsule.
Motirka USA Inc (part of Hobart Healthcare)
United States
US subsidiary of Israel's Motorika Medical; markets ReoAmbulator and ReoGo robotic rehabilitation systems for gait and upper-limb neurological therapy.
UCSD Healthcare Robotics Lab
United States
UCSD robotics research lab led by Prof. Laurel Riek; focuses on human-robot teaming, assistive care robots, and healthcare AI in clinical settings.
Robotics needs a service framework.
RSF defines a common language for robot service capability, lifecycle operations, certification pathways, and service-provider networks.
Join the RobotToday community on LinkedIn
Daily robotics news, in-depth analysis, conference highlights, and discussions with professionals worldwide.
